Liberty Health Sciences to be exclusive distributor of Isodiol International products throughout Florida and Massachusetts Cannabis Investing News
Clovis Oncology Announces European Commission Authorization of Rubraca (rucaparib) for Women with Recurrent Ovarian Cancer Pharmaceutical Investing
BioTime Announces $1.9 Million Grant for Continued Development of OpRegen® for Dry-AMD Biotech Investing
Phase III IMpower130 Study Showed Genentech’s TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin and ABRAXANE) Helped People With Metastatic Non-Squamous Non-Small Cell Lung Cancer Live Significantly Longer Compared to Chemotherapy Alone Pharmaceutical Investing
Novel First-In-Class Immunotherapeutic APVO210 Features Unique Mechanism of Action Delivering IL-10 Biotech Investing
RedHill Biopharma Announces New U.S. Patent for its Experimental Ebola Therapy Pharmaceutical Investing
“Avitas CBD Water, LLC” Rebranded As “Xanthic Beverages” and First Production to be Distributed to Over 500 Retail Locations Biotech Investing
Isodiol International Inc. Announces Closing of Strategic Non-Brokered Offering for Total Proceeds of $18 Million Cannabis Investing News
